| Tag | Content |
|---|
EnhancerAtlas ID | HS081-15942 |
Organism | Homo sapiens |
Tissue/cell | HACAT |
Coordinate | chr5:131725160-131725880 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOSL1 | MA0477.1 | chr5:131725569-131725580 | GATGAGTCACC | - | 6.32 | | FOSL2 | MA0478.1 | chr5:131725453-131725464 | ATGAGTCACCC | - | 6.14 | | FOSL2 | MA0478.1 | chr5:131725570-131725581 | ATGAGTCACCC | - | 6.14 | | JUNB | MA0490.1 | chr5:131725453-131725464 | ATGAGTCACCC | - | 6.32 | | JUNB | MA0490.1 | chr5:131725570-131725581 | ATGAGTCACCC | - | 6.32 | | JUND | MA0491.1 | chr5:131725569-131725580 | GATGAGTCACC | - | 6.62 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_26597 | chr5:131723314-131726622 | Esophagus | | SE_54554 | chr5:131720956-131726150 | Stomach_Smooth_Muscle | | SE_62219 | chr5:131721125-131837948 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH05I132384 | chr5 | 131720053 | 131726700 |
|
Enhancer Sequence | ATAAACGGTC CTGGAGTCAG GGCTATAGCC TAGATGTCCT TACCAGGTTC CCACTAATGA 60
GGCAAAGTAT GTCAGAAAGG GATTTGTGAA TTACCAGGGA GAGGAAACAT GTCCAAGTGC 120
ACATCGCTAG CTTTTGCTCA GCGGCCGAAC CCTGGGATTC TAGGCGACTT CTGGAGCCTG 180
GTGGGTTAGC GGTGAGAAGA TGGGCGAGGA GGGCGGACTT CATCTCAGAG TCCTTATTAC 240
TAGTCTCATC CAGCTTTGAG GCAGTCAGCC ACTGTGCCTA CTGAGGGAGT GCTATGAGTC 300
ACCCGCTTCC AAGGAATGGC CCAGGATCCC TCCAGGCAGT TCACCATTCC CTGAGTTGGC 360
CTCAAGACAG GAGCAGCATG TAGCCTGCAC CACAGACATG CAAGCCTGTG ATGAGTCACC 420
CACTTTTGTG TTCACCCAGG CTCTCCTCCC TGCTCTGGAT TTCCTGGGGA CTCATGCACA 480
TACTCTTTTT ATTGTACCAG CTGTGTGTTC CACCTGCAGA TGAGTCAAAA CAGTCTAATC 540
CATAAAGGTC TGGTTTGTCA AAGAGTGTGG GTCATCAACA GAGAGAATGC CTACTGGGGA 600
TGCCCAGGTC AGGGGTACTG CAGGGCATCC TGATGAGAGG CAGTGTGGCC CCTCCATTGG 660
GAGCCACCTC TGTGCTCCAC AAGTACCGCG GGGCTGGTGT CAGCTGTCTC TGACCAGCCT 720
|
